Hoppa till innehåll
VuFind
    • English
    • Deutsch
    • Español
    • Français
    • Italiano
    • 日本語
    • Nederlands
    • Português
    • Português (Brasil)
    • 中文(简体)
    • 中文(繁體)
    • Türkçe
    • עברית
    • Gaeilge
    • Cymraeg
    • Ελληνικά
    • Català
    • Euskara
    • Русский
    • Čeština
    • Suomi
    • Svenska
    • polski
    • Dansk
    • slovenščina
    • اللغة العربية
    • বাংলা
    • Galego
    • Tiếng Việt
    • Hrvatski
    • हिंदी
    • Հայերէն
    • Українська
    • Sámegiella
    • Монгол
Avancerad
  • MEK1/2 blockade by AZD6244 (AR...
  • Hänvisa
  • Textmeddelande
  • Skicka per e-post
  • Skriv ut
  • Exportera posten
    • Exportera till: RefWorks
    • Exportera till: EndNoteWeb
    • Exportera till: EndNote
  • Permanent länk
MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib

MEK1/2 blockade by AZD6244 (ARRY-142886) inhibits tumor growth and progression in an orthotopic human lung adenocarcinoma model with enhanced efficacy when combined with cediranib

Bibliografiska uppgifter
Huvudupphovsmän: Takahashi, O, Komaki, R, Smith, P, Ryan, A, Jurgensmeier, J, Welsh, J, Jacoby, J, Hosho, K, Korshunova, M, Erez, B, Herbst, R, O'Reilly, MS
Materialtyp: Journal article
Publicerad: 2009
  • Beståndsuppgifter
  • Beskrivning
  • Liknande verk
  • Katalogiseringsuppgifter

Liknande verk

  • DOC-MEK: A double-blind randomized phase II trial of docetaxel with or without selumetinib (AZD6244; ARRY-142886) in wt BRAF advanced melanoma
    av: Gupta, A, et al.
    Publicerad: (2013)
  • AZD6244 (ARRY-142886) vs temozolomide (TMZ) in patients (pts) with advanced melanoma: An open-label, randomized, multicenter, phase II study
    av: Dummer, R, et al.
    Publicerad: (2008)
  • Author Correction: Targeting inhibition of extracellular signal-regulated kinase kinase pathway with AZD6244 (ARRY-142886) suppresses growth and angiogenesis of gastric cancer
    av: Jin-Hang Gao, et al.
    Publicerad: (2022-03-01)
  • Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis.
    av: Takahashi, O, et al.
    Publicerad: (2012)
  • Combined MEK and VEGFR inhibition in orthotopic human lung cancer models results in enhanced inhibition of tumor angiogenesis, growth, and metastasis
    av: Takahashi, O, et al.
    Publicerad: (2012)

Sökalternativ

  • Sökhistorik
  • Avancerad sökning

Sök mera

  • Bläddra i katalogen
  • Bläddra alfabetiskt
  • Utforska kanaler
  • Kursböcker
  • Nytt i katalogen

Behöver du hjälp?

  • Söktips
  • Fråga biblioteket
  • Vanliga frågor